GINKGO Spirig HC cpr pellic 240 mg 30 pce

7680683620011 CH-68362 N06DX02 02.97.0.
GINKGO Spirig HC cpr pellic 240 mg 30 pce
Fiches Amavita / Sun Store / Coop Vitality

Details

Product number
6836201
CPT
-
Packaging group
30
Unit
Tablette(n)
Composition
ginkgonis extractum siccum raffinatum et quantificatum (Ginkgo biloba L., folium) 240.000 mg corresp. flavonglycosida ginkgo 52.8-64.8 mg et bilobalidum 6.24-7.68 mg et ginkgolidae A, B et C 6.72–8.16 mg, DER: 35-67:1, Auszugsmittel acetonum 60 % (m/m), glucosum liquidum dispersione desiccatum 12.632 mg, lactosum 375.368 mg, silica hydrophobica colloidalis, cellulosum microcristallinum, acidum citricum, ricini oleum hydrogenatum, talcum, magnesii stearas, Überzug: copolymerum methacrylatis butylati basicum, natrii laurilsulfas, acidum stearicum, talcum, E 172 (flavum), saccharinum natricum, vanillinum, natrium 0.139 mg, pro compresso.

Articles (1)

Ginkgo Spirig HC 240 mg, Filmtabletten
Filmtabletten
30
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
16/07/2024
Professional SmPC
Français
16/07/2024
Patient information leaflet
Allemand
25/10/2022
Patient information leaflet
Français
25/10/2022
Patient information leaflet
Italien
25/10/2022

Detailed composition

Substance Quantity Type Category
ginkgonis extractum siccum raffinatum et quantificatum
240.0 MG Substance Wirkstoff (Principe actif)
flavonglycosida ginkgo
- Substance WIIS
bilobalidum
- Substance WIIS
ginkgolidae A, B et C
- Substance WIIS
glucosum liquidum dispersione desiccatum
12.632 MG Substance HBESI
lactosum
375.368 MG Substance HBESI
silica hydrophobica colloidalis
- Substance HNIDK
cellulosum microcristallinum
- Substance HNIDK
acidum citricum
- Substance HNIDK
ricini oleum hydrogenatum
- Substance HNIDK
talcum
- Substance HNIDK
magnesii stearas
- Substance HNIDK
copolymerum methacrylatis butylati basicum
- Substance HNIDK
natrii laurilsulfas
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
acidum stearicum
- Substance HNIDK
talcum
- Substance HNIDK
E 172 (flavum)
- Substance FTODK
saccharinum natricum
- Substance AIMDK
vanillinum
- Substance AIMDK
natrium
0.139 MG Substance HBESI

Reimbursement information

Public price
CHF 48.00
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/01/2023

Authorization holder

Spirig HealthCare AG

4622 Egerkingen

Authorization information

Swissmedic authorization number
68362
Drug name
Ginkgo Spirig HC, Filmtabletten
Galenic form
FILM
ATC Code
N06DX02
Authorization status
Z
Dispensation category
B
First authorization
15/07/2022
Authorization expiration date
14/07/2027
IT number
02.97.0.
Domain
Human medicine
Field of application
Zur symptomatischen Behandlung von Einbussen in der mentalen Leistungsfähigkeit, bei Claudicatio intermittens, bei Vertigo und Tinnitus.

Packaging details

Description (FR)
GINKGO Spirig HC cpr pellic 240 mg 30 pce
Description (DE)
GINKGO Spirig HC Filmtabl 240 mg 30 Stk
Market launch
15/07/2022
Narcotic (BTM)
No

Other packaging sizes

GINKGO Spirig HC cpr pellic 240 mg 90 pce
90 TABL
View
Buy us a coffee Explore the data